Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People
NCT00418470 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2015-10-29
Summary
Patients with cystic fibrosis (CF) need to frequently undergo courses of IV antibiotic therapy. To avoid a high number of venipunctures peripheral venous catheters (SPVC) or cannulas are used. Because of the irritant action of the drugs used, SPVC's often do not last for the whole antibiotic course (usually of two weeks) and the patient has to be punctured again for the insertion of a new IV line. With the passing of time the veins are more difficult to be found. An alternative to the use of a cannulas is the surgical insertion of a central venous catheter. This intervention may have contraindications or, specially in adolescents, cause unacceptable alterations of the body image.
The aim of this study is to find a way to prolong the duration of the SPVC used by CF patients during antibiotic courses avoiding the irritation of the vein or a phlebitis.
Design of the study: randomized controlled trial. The study will see a collaboration of nurses, physicians and technicians of the Tuscan CF Centre.
The patients that will participate at the study will be randomly assigned to one of the two groups: one group will receive the antibiotics prescribed according to the maximal dilution suggested by the pharmaceutical company, the other will receive a much higher dilution (i.e. a higher volume of Normal Saline), but the time of administration will be the same.
The assessment will regard: the level of inflammation of the vein (with a special visual scale) and the duration of the SPVC.
The hypothesis that is to be proved is that diluting the antibiotic in a higher volume of Normal Saline it is possible to delay or prevent the irritation of the vein and the onset of a phlebitis.
In case that the hypothesis will be confirmed by this study an easy, secure, low cost and immediately available system will be available to reduce the number of venipunctures necessary to complete a course of IV antibiotics.
Conditions
- Cystic Fibrosis
- Phlebitis
Interventions
- PROCEDURE
-
regular dilution of antibiotic in NS
IV administration of ceftazidime tid diluted in regular NS volume
- PROCEDURE
-
higher dilution of antibiotic in NS
IV administration of ceftazidime tid diluted in larger NS volume
Sponsors & Collaborators
-
Italian Cystic Fibrosis Research Foundation
collaborator OTHER -
Ospedale Meyer
collaborator OTHER -
University of Florence
lead OTHER
Principal Investigators
-
Filippo Festini, RN, BA, BSN · University of Florence, Department of Pediatrics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- Italy
Study Locations
More Related Trials
-
A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis
NCT01667094 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis
NCT01509339 ·Status: WITHDRAWN ·Phase: PHASE1
-
Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis
NCT02694393 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF)
NCT00670579 ·Status: COMPLETED
-
Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
NCT00763412 ·Status: COMPLETED ·Phase: NA
-
Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis
NCT05561764 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients
NCT01158937 ·Status: TERMINATED ·Phase: NA
-
Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
NCT00333385 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis Patients
NCT01658449 ·Status: COMPLETED ·Phase: NA
-
Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients
NCT00376428 ·Status: TERMINATED ·Phase: PHASE2
-
Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years
NCT02803944 ·Status: COMPLETED
-
Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients
NCT00274313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis
NCT02141958 ·Status: COMPLETED ·Phase: PHASE1
-
The Addition of Non-Invasive Ventilation To Airway Clearance Techniques In Adults With Cystic Fibrosis
NCT01885650 ·Status: TERMINATED ·Phase: NA
-
Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients
NCT02421120 ·Status: COMPLETED ·Phase: PHASE4
-
Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis
NCT02303808 ·Status: COMPLETED ·Phase: NA
-
Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis
NCT02083263 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Omadacycline in Cystic Fibrosis
NCT04460586 ·Status: COMPLETED ·Phase: PHASE4
-
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
NCT01429259 ·Status: COMPLETED ·Phase: PHASE4
-
Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis
NCT01694069 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Study of Pregnancy in Women With Cystic Fibrosis
NCT04828382 ·Status: ACTIVE_NOT_RECRUITING
-
Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation
NCT02480270 ·Status: COMPLETED
-
Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
NCT02504827 ·Status: COMPLETED ·Phase: PHASE4
-
Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device
NCT04743206 ·Status: TERMINATED ·Phase: NA
-
The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis
NCT00271310 ·Status: COMPLETED ·Phase: PHASE3